Location History:
- Little Rock, AR (US) (2007 - 2014)
- Salt Lake City, UT (US) (2015 - 2020)
Company Filing History:
10 out of 836 
3 out of 92 
1 out of 832,718 Years Active: 2007-2020
Title: Innovator in Cancer Research: Fenghuang Zhan
Introduction
Fenghuang Zhan, an accomplished inventor based in Little Rock, Arkansas, has made significant contributions to the field of cancer research, specifically in multiple myeloma. With a remarkable portfolio of 14 patents, Zhan has focused on pioneering methods for using gene expression profiling to improve diagnosis and prognosis in cancer patients. His innovative work has the potential to change the landscape of cancer treatment.
Latest Patents
Among Zhan’s most recent patents are groundbreaking innovations such as "Use of gene expression profiling to predict survival in cancer patients" and "Diagnosis, prognosis and identification of potential therapeutic targets of multiple myeloma based on gene expression profiling." The first patent identifies key genes like ASPM, OPN3, and CKS1B, which are linked to poor survival rates in multiple myeloma patients. These findings suggest that these genes could serve as powerful prognostic markers and therapeutic targets for various cancers. The second patent details the utility of gene expression profiling to classify multiple myeloma into subtypes, allowing identification of genes that contribute to poor prognosis. Notably, the CKS1B gene, often amplified in high-risk cases, is a focal point for potential targeted therapies.
Career Highlights
Throughout his career, Zhan has been affiliated with respected organizations, notably the University of Arkansas and Bioventures, LLC. His academic and professional endeavors have been driven by a commitment to enhancing cancer care through innovative research.
Collaborations
Zhan's work is often shared with industry leaders and co-researchers such as John D. Shaughnessy and Bart Barlogie. These collaborations have fostered a multidimensional approach to understanding and treating multiple myeloma, enriching the overall research environment.
Conclusion
Fenghuang Zhan’s contributions to cancer research through his innovative patents highlight the critical importance of gene expression profiling in treatment and prognosis across various cancers. His work not only advances scientific understanding but also holds promise for developing targeted therapies that could improve patient outcomes significantly. As his research continues to evolve, the impact of his inventions will undoubtedly be felt in the medical community and beyond.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.